Guardant Health has priced an upsized public offering of 12.5M shares at $28.00 per share, with gross proceeds of of $350M
Portfolio Pulse from Benzinga Newsdesk
Guardant Health has priced an upsized public offering of 12.5 million shares at $28.00 per share, raising gross proceeds of $350 million.
May 23, 2023 | 8:11 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Guardant Health's upsized public offering of 12.5 million shares at $28.00 per share raises $350 million in gross proceeds.
Guardant Health's upsized public offering will raise $350 million in gross proceeds, which can be used for various corporate purposes. This news is directly related to the company and its stock price, but the short-term impact on the stock price is uncertain as it depends on how the market perceives the offering and the company's plans for the raised funds.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100